Literature DB >> 26730251

Strategy of Revascularization for Critical Limb Ischemia Due to Infragenicular Lesions-Which Should Be Selected Firstly, Bypass Surgery or Endovascular Therapy?

Takahiro Ohmine1, Kazuomi Iwasa1, Terutoshi Yamaoka1.   

Abstract

BACKGROUND AND OBJECTIVES: In patients with peripheral arterial diseases (PADs) due to infra-popliteal (below the knee; BTK) lesions, we often encounter situations requiring the immediate selection of either of two revascularization methods, namely bypass surgery or endovascular therapy (EVT). However, the question of whether endovascular or surgical revascularization should be performed initially for critical limb ischemia (CLI) patients with BTK lesions has not been clarified. To assess the efficacy and durability of EVT or bypass as a first approach, we evaluated the short- and mid-term outcomes of the first revascularizations achieved using EVT (EVT First Group; EVT-first) compared with bypass (Bypass First Group; Bypass-first). To verify the validity of each initial revascularization, we explored factors influencing overall survival (OS) rates using multivariate analyses.
METHODS: A total of 169 consecutive BTK revascularization procedures (150 patients) for CLI conducted at our facility between November 2006 and July 2012 were analyzed. Patients undergoing revascularization were divided into two groups (EVT-first or Bypass-first), with 102 patients undergoing endovascular therapy first (EVT-first) and 51 undergoing bypass surgery first (Bypass-first). No statistically significant differences were noted between the two groups with respect to preoperative background including age, gender, and cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, coronary arterial disease (CAD), chronic heart failure (CHF), cerebrovascular disease, and hemodialysis). Technical success was defined as a single straight-line flow to the ankle after completion angiography of the first revascularization method. Hemodynamic success was defined as a postoperative skin perfusion pressure of the foot exceeding 40 mmHg.
RESULTS: The average age of patients was 76.0 years (range, 46-98 years; 65 men and 37 women) and 72.3 years (range, 43-93 years; 35 men and 13 women) in the EVT-first and Bypass-first groups, respectively. Patient follow-up ranged from 1 to 50 months (mean, 15 months). Respective technical and hemodynamic success rates were 96.2% and 66.7% for EVT-first and 100% and 94% for Bypass-first, respectively. Treatment was required an average of 1.5 times for EVT-first and 1.2 times for Bypass-first. Respective rates for other factors examined in the EVT-first and the Bypass-first groups were: major amputation rates 30 days post-procedure, 5.9%, and 3.9%; mortality rates 30 days post-procedure, 3.9%, and 0%; one-year AFS rates, 71.7%, and 79.5%; OS rates, 73.5% and 83.9%; and limb salvage rates, 88.8%, and 91.0%. Multivariate-analysis of all subjects in the two groups revealed that the OS rates were affected by four risk factors as follows: (1) age greater than 80 years, (2) CAD, (3) CHF, and (4) a non-ambulatory limb.
CONCLUSION: For patients with CLI due to BTK lesions and whose saphenous veins are in poor condition or are in poor general condition having two or more of the four severe risk factors, the EVT-First procedure is effective and provides durable results. Overall survival in patients with CLI due to BTK lesions is worse when patients have more than two severe risk factors, which is non-ambulatory limb, aged less than 81 years, with CAD or with CHF. (This article is a translation of Jpn J Vasc Surg 2014; 23: 766-773.).

Entities:  

Keywords:  below the knee lesions; bypass surgery; critical limb ischemia; endovascular therapy; peripheral arterial diseases

Year:  2015        PMID: 26730251      PMCID: PMC4691500          DOI: 10.3400/avd.oa.15-00076

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  14 in total

1.  Contemporary outcomes after endovascular treatment for aorto-iliac artery disease.

Authors:  Yoshimitsu Soga; Osamu Iida; Daizo Kawasaki; Yasutaka Yamauchi; Kenji Suzuki; Keisuke Hirano; Ryoji Koshida; Daisuke Kamoi; Junichi Tazaki; Michiaki Higashitani; Yoshiaki Shintani; Terutoshi Yamaoka; Shinya Okazaki; Nobuhiro Suematsu; Taketsugu Tsuchiya; Yusuke Miyashita; Norihiko Shinozaki; Hiroki Takahashi
Journal:  Circ J       Date:  2012-08-02       Impact factor: 2.993

2.  Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received.

Authors:  Andrew W Bradbury; Donald J Adam; Jocelyn Bell; John F Forbes; F Gerry R Fowkes; Ian Gillespie; Charles Vaughan Ruckley; Gillian M Raab
Journal:  J Vasc Surg       Date:  2010-05       Impact factor: 4.268

3.  Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.

Authors:  Yoshimitsu Soga; Osamu Iida; Keisuke Hirano; Hiroyohi Yokoi; Shinsuke Nanto; Masakiyo Nobuyoshi
Journal:  J Vasc Surg       Date:  2010-06-22       Impact factor: 4.268

4.  Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.

Authors:  Francesco Liistro; Italo Porto; Paolo Angioli; Simone Grotti; Lucia Ricci; Kenneth Ducci; Giovanni Falsini; Giorgio Ventoruzzo; Filippo Turini; Guido Bellandi; Leonardo Bolognese
Journal:  Circulation       Date:  2013-08-06       Impact factor: 29.690

5.  Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry.

Authors:  Kenji Suzuki; Osamu Iida; Yoshimitsu Soga; Keisuke Hirano; Naoto Inoue; Masaaki Uematsu; Hiroyoshi Yokoi; Toshiya Muramatsu; Shinsuke Nanto; Masakiyo Nobuyoshi; Taiichiro Meguro
Journal:  Circ J       Date:  2011-02-11       Impact factor: 2.993

Review 6.  Understanding objective performance goals for critical limb ischemia trials.

Authors:  Michael S Conte
Journal:  Semin Vasc Surg       Date:  2010-09       Impact factor: 1.000

7.  Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.

Authors:  Maria Teresa B Abola; Deepak L Bhatt; Sue Duval; Patrice P Cacoub; Iris Baumgartner; Hong Keo; Mark A Creager; Danielle M Brennan; Ph Gabriel Steg; Alan T Hirsch
Journal:  Atherosclerosis       Date:  2012-01-24       Impact factor: 5.162

8.  Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia.

Authors:  M Söderström; E Arvela; A Albäck; P-S Aho; M Lepäntalo
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-03-20       Impact factor: 7.069

9.  Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up.

Authors:  Osamu Iida; Masato Nakamura; Yasutaka Yamauchi; Daizo Kawasaki; Yoshiaki Yokoi; Hiroyoshi Yokoi; Yoshimistu Soga; Kan Zen; Keisuke Hirano; Nobuhiro Suematsu; Naoto Inoue; Kenji Suzuki; Yoshiaki Shintani; Yusuke Miyashita; Kazushi Urasawa; Ikuro Kitano; Terutoshi Yamaoka; Takashi Murakami; Michitaka Uesugi; Taketsugu Tsuchiya; Toshiro Shinke; Yasuhiro Oba; Norihiko Ohura; Toshimitsu Hamasaki; Shinsuke Nanto
Journal:  Circ Cardiovasc Interv       Date:  2013-01-29       Impact factor: 6.546

10.  2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors: 
Journal:  Circulation       Date:  2011-09-29       Impact factor: 29.690

View more
  6 in total

Review 1.  Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.

Authors:  Ahmet Yuksel; Yusuf Velioglu; Mustafa Cagdas Cayir; Gencehan Kumtepe; Orcun Gurbuz
Journal:  Int J Angiol       Date:  2018-01-22

2.  Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.

Authors:  Thomas C F Bodewes; Jeremy D Darling; Sarah E Deery; Thomas F X O'Donnell; Alexander B Pothof; Katie E Shean; Frans L Moll; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-08-24       Impact factor: 4.268

3.  Comparison of perfusion values after percutaneous transluminal angioplasty according to the severity of ischaemia in the diabetic foot.

Authors:  Sik Namgoong; Jong-Phil Yang; Ki-Hyun Yoo; Seung-Kyu Han; Seung-Woon Rha; Ye-Na Lee
Journal:  Int Wound J       Date:  2018-10-12       Impact factor: 3.315

4.  Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.

Authors:  Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza
Journal:  J Atheroscler Thromb       Date:  2020-07-04       Impact factor: 4.928

5.  Distal Bypass to the Palmar Arch to Rescue Digital Ischemia Due to Peripheral Artery Disease.

Authors:  Tsukasa Nakamura; Shuji Nobori; Kiyokazu Akioka; Koji Masuda; Shumpei Harada; Masafumi Osaka; Takehisa Matsuyama; Norio Yoshimura; Hidetaka Ushigome
Journal:  Ann Vasc Dis       Date:  2018-09-25

6.  Comprehensive Assessment of Current Management Strategies for Patients With Diabetes and Chronic Limb-Threatening Ischemia.

Authors:  Shirli Tay; Sami Abdulnabi; Omar Saffaf; Nikolai Harroun; Chao Yang; Clay F Semenkovich; Mohamed A Zayed
Journal:  Clin Diabetes       Date:  2021-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.